COVID Vaccine Monitor study- Help us monitor the safety of COVID-19 vaccines in the UK

Go to registration
More information

Why do this study?

The coronavirus (COVID-19) vaccines have been researched thoroughly before being given to the public. Only by being well researched may they be used. However, side effects after vaccination are always a possibility. The Drug Safety Research Unit would like to monitor this information. By doing so we will learn more about possible side effects as quickly as possible. Please find further information about the study in the Participant Information sheet.

Am I allowed to participate?

You may participate if you received your BOOSTER COVID-19 vaccine no longer than two days ago or you will be getting it soon.

If you would like to participate, please click here to start.

What do I need to keep in mind if I participate?

To be able to participate, you must register first. After registration you will receive a questionnaire with some general questions. Seven days after vaccination, you will receive the next questionnaire. In total you will receive six questionnaires over a period of approx. 3 months. Questionnaires need to be filled in via the study website. Each questionnaire takes 10-25 minutes to fill in. The questions are about the possible side effects that you may have experienced after vaccination. Even if you do not experience any side effects, we ask that you complete the questionnaires. Participation is completely voluntary. You can stop your participation at any time without explanation.

What will be done with my data?

Storage and security of your data will comply with General Data Protection Regulation (GDPR). For more information, please read the DSRU privacy statement.

Which side effects could I expect?

After any vaccination, a reaction can happen at the site of injection. It can be painful, red and/or swollen. You may feel generally unwell for a few days after the vaccination. Side effects such as headache, fever and muscle ache can also occur. For more information on COVID-19 vaccines and their side effects please visit: www.gov.uk/government/publications/covid-19-vaccination-what-to-expect-after-vaccination/what-to-expect-after-your-covid-19-vaccination

Most side effects occur within two days of vaccination, and they disappear within a few days. If you have any questions about possible side effects of COVID-19 vaccines, contact your GP.

Do you have questions about the study?

Please take a look at the FAQs. You may also contact Drug Safety Research Unit at covidmonitor@dsru.org

Any suspected side effects to COVID-19 vaccines can also be reported directly to the Medicines and Healthcare products Regulatory Agency (MHRA) on the Coronavirus Yellow Card reporting site below. This is a government system which is used to monitor the safe and effective use of COVID-19 vaccines and treatments available in the UK. https://coronavirus-yellowcard.mhra.gov.uk

Registration form

Mandatory questions in this registration form are marked with an asterisk (*).

The question below relates to the vaccinated. This can be yourself or the person for whom you want to enter the data:

i
id: b890f361-3ce1-4513-ad29-7f50e958fdda

Question *

Are you filling in this form for yourself or on behalf of your child or on behalf of another person?

i
id: 6b2bd2b8-e116-4f17-914d-ad6aba1522d9

Question *

Are you 16 years or older?

i
id: c22d5651-a4d1-47ab-ba3c-b1846eb3aa14

Question *

Do you fall into one of the special target groups?
Please note: Multiple answers can be selected.

** Examples of conditions that could affect the immune system: HIV/AIDS, transplants, autoimmune diseases (such as systemic lupus erythematosus, rheumatoid arthritis, psoriasis, psoriatic arthritis), leukaemia/lymphoma, or other disease that is affecting the immune system. Examples of immunosuppressant medications: medication for cancer or for chronic inflammatory conditions such as rheumatism, medication related to a compromised immune system, or medication to prevent rejection reactions after organ transplantation.

i
id: cec4098f-7c1d-4670-816b-052d193187a1

Question *

With which booster vaccine have you been, or will you be vaccinated with?

i
id: e17a7990-57d7-4c95-86c3-9e0aeee32fed

Question *

Which situation applies to you?

Note: This is about the booster vaccination.

i
id: 87f83369-ed60-4874-8a1a-9de4ad3b2138

Question *

On what date will you be receiving the COVID-19 booster vaccine? Please check your vaccination invitation if you have one.

i
id: ce5536f8-a21a-4f5e-a032-c8b9065e92f5

Question *

On which date did you have your COVID-19 booster vaccine?

i
id: 6b1eb2d1-707d-4cf6-91ac-3d8df06ac01f

PURPOSE OF THIS STUDY
The purpose of this study is to gather information on side effect (adverse reactions) caused by the COVID-19 booster vaccine. We will also compare reported suspected adverse reaction(s) between the different coronavirus vaccines. To expand the existing knowledge about the COVID-19 booster vaccines, it is important to gather information on possible adverse reactions in a structured way.

Who can participate?

  • Persons above 16 years old and soon receiving theCOVID-19 booster vaccine, or having received the COVID-19 booster vaccine no more than 2 days ago.

Informed consent
Questions which require an answer in this registration form are marked with an asterisk (*).

In order to participate with the COVID Vaccine Monitor study we need your consent. You will be asked to provide some general information. As soon as your informed consent has been submitted you will receive an email with a link to login get access to your questionnaires. To login you will receive a username and password seperately.

If you have any questions do not hesitate to contact the Drug Safety Research Unit by e-mail covidmonitor@dsru.org or telephone 02380 408600.
  • I have read the privacy statement and the information regarding this study. Any questions I had were answered by contacting the Drug Safety Research Unit.
  • I understand that participation is voluntary. I understand that I can decide at any time to stop my participation in this study and do not need to give a reason for my decision.
  • I understand that all information provided will be treated with strict confidentiality.
  • I give permission for my data to be used for the purpose of this study, namely, to gather information and expand the existing knowledge about the COVID-19 vaccines. It is important for the Drug Safety Research Unit to know precisely which vaccine brand was administered in order to compare the reported suspected adverse reaction between the administered coronavirus vaccines, gaining more insight in the relevant medical history of participants, reported adverse reactions, the nature of these reactions, the course of these reactions, possible risk factors and the consequences related to health.
  • I understand that my email address will only be used for registration and communication with the Drug Safety Research Unit
  • I understand that my data, except for personal data such as email address, postcode and date of birth, could be used for the wider European study. Several European countries will perform a similar study. Results of this study will be compared to each other. Any data shared for this purpose will be anonymous.
  • I am 16 years or older.

i
id: f42ab2bd-8c6b-4783-9526-6339e6741448

Sometimes additional information about reported suspected adverse reactions is necessary. In this case we would like to be able to contact you. By doing so we are able to have complete and reliable data on the medical situation which essential for this study.

I give permission to be contacted for extra information about the reported suspected adverse reactions.

i
id: 9557ae16-a50c-4611-91fb-32221ee404c1

I give permission to be contacted by telephone for extra information about my pregnancy in case some information is lacking or some information is not entirely clear.

i
id: b118e0fc-dc58-4489-94c2-5e01e12a8efa

Question *

Please enter your phone number

i
id: 423dcf13-7787-40ac-8e2d-ccc1c52ab108

Question *

What is your Email address?
This is the email address where the emails will be received.

i
id: 127ebeb5-75a9-422a-88d0-820866ca0869

Question *

What is your postal code?

i
id: 7b801018-0923-4aea-af50-a7f2a2ea277f

Question *

What is your first name?

i
id: 6dd64337-de01-483d-9a80-94e112339e19

Question *

What is your year of birth?

i
id: eb436617-d2d4-4627-91a3-69bed7e8f005

Question *

Are you 16 years or older?

i
id: 60bbb4d9-cc72-4069-ab80-f03ac429790c

Question

Does your child fall into one of the special target groups?
Please note: Multiple answers can be selected.

** Examples of conditions that could affect the immune system: HIV/AIDS, transplants, autoimmune diseases (such as systemic lupus erythematosus, rheumatoid arthritis, psoriasis, psoriatic arthritis), leukaemia/lymphoma, or other disease that is affecting the immune system. Examples of immunosuppressant medications: medication for cancer or for chronic inflammatory conditions such as rheumatism, medication related to a compromised immune system, or medication to prevent rejection reactions after organ transplantation.

i
id: cec6cc2c-383e-44df-92a6-0e5f9fb639d5

Question *

Which booster vaccine has your child been, or will your child be, vaccinated with?

i
id: 650a1271-2de0-4867-8674-1b0bec0affbd

Question *

Which situation applies to your child?

Note: This is about the booster vaccination.

i
id: f9c01226-f6a7-4761-a2d7-abd62f49c8c9

Question *

On what date will your child be receiving the COVID-19 booster vaccine? Please check the vaccination invitation if he/she has one.

i
id: 9e7127fe-5f8a-4086-b742-0a4d6de2ab93

Question *

On which date did your child have his/her COVID-19 booster vaccine?

i
id: e2f2a4ee-95e4-4989-a51a-bee6f0708383

PURPOSE OF THIS STUDY
The purpose of this study is to gather information on side effect (adverse reactions) caused by the COVID-19 booster vaccine. We will also compare reported suspected adverse reaction(s) between the different coronavirus vaccines. To expand the existing knowledge about the COVID-19 booster vaccines, it is important to gather information on possible adverse reactions in a structured way.

Who can participate?

  • A child under 18 years (who you will fill in the questionnaires for) who will soon receive the COVID-19 booster vaccine or who has received the COVID-19 booster vaccine no more than 2 days ago.

Informed consent
Questions which require an answer in this registration form are marked with an asterisk (*).
In order to participate with the COVID Vaccine Monitor study we need your consent. You will be asked to provide some general information. As soon as your informed consent has been submitted you will receive an email with a link to login get access to your questionnaires. To login you will receive a username and password seperately.

If you have any questions do not hesitate to contact the Drug Safety Research Unit by e-mail covidmonitor@dsru.org or telephone 02380 408600.
  • I have read the privacy statement and the information regarding this study. Any questions I had were answered by contacting the Drug Safety Research Unit.
  • I understand that participation is voluntary. I understand that I can decide at any time to stop the participation of my child in this study and do not need to give a reason for my decision.
  • I understand that all information provided will be treated with strict confidentiality.
  • I give permission for data of my child to be used for the purpose of this study, namely, to gather information and expand the existing knowledge about the COVID-19 vaccines. It is important for the Drug Safety Research Unit to know precisely which vaccine brand was administered in order to compare the reported suspected adverse reaction between the administered coronavirus vaccines, gaining more insight in the relevant medical history of participants, reported adverse reactions, the nature of these reactions, the course of these reactions, possible risk factors and the consequences related to health.
  • I understand that my email address will only be used for registration and communication with the Drug Safety Research Unit
  • I understand that my data, except for personal data such as email address, postcode and date of birth, could be used for the wider European study. Several European countries will perform a similar study. Results of this study will be compared to each other. Any data shared for this purpose will be anonymous.
  • I am 16 years or older.

i
id: d83f9365-3a44-495e-8ead-e8f7bdf974d2

Sometimes additional information about reported suspected adverse reactions is necessary. In this case we would like to be able to contact you. By doing so we are able to have complete and reliable data on the medical situation which essential for this study.

I give permission to be contacted for extra information about the reported suspected adverse reactions.

i
id: 78dfa83e-a435-4dd8-b2ce-58b61034fa87

I give permission to be contacted by telephone for extra information about her pregnancy in case some information is lacking or some information is not entirely clear.

i
id: faeb6b19-6d29-4356-a96e-615d163434de

Question *

Please enter your phone number

i
id: 343120b6-ab70-4b2f-b101-9e19d186f565

Question *

What is your Email address?
This is the email address where the emails will be received.

i
id: b1b8508e-895b-49d4-a509-651c09cd5a0f

Question *

What is his/her postal code?

i
id: 914cfabb-a3ee-4376-a300-5a9db5c6f75b

Question *

What is his/her first name?

i
id: 5a5e6ade-317b-4a38-ab20-ee1abc88d5b6

Question *

What is his/her year of birth?

i
id: dea6318b-d135-4ce3-9304-de1f200f8938

Question *

Are you 16 years or older?

i
id: 4a9e64c5-004c-4a5e-b628-3eb65d929f75

Question *

Does the person you represent fall into one of the special target groups?
Please note: Multiple answers can be selected.

** Examples of conditions that could affect the immune system: HIV/AIDS, transplants, autoimmune diseases (such as systemic lupus erythematosus, rheumatoid arthritis, psoriasis, psoriatic arthritis), leukaemia/lymphoma, or other disease that is affecting the immune system. Examples of immunosuppressant medications: medication for cancer or for chronic inflammatory conditions such as rheumatism, medication related to a compromised immune system, or medication to prevent rejection reactions after organ transplantation.

i
id: e8e4ca6d-f77a-4597-934e-c568e1e4d431

Question *

Which booster vaccine has the person you represent been vaccinated with or will he/she be vaccinated with?

i
id: 0e58aec6-1dd7-46aa-a384-2dd12c1e18b2

Question *

Which situation applies to him/her?

i
id: cb53b590-d794-491a-895c-d8994820a47f

Question *

On what date will he/she be receiving the COVID-19 booster vaccine? Please check the vaccination invitation if he/she has one.

i
id: 6dce9428-4c4a-4533-bd3a-94f20a39056f

Question *

On which date did he/she have his/her COVID-19 booster vaccine?

i
id: ee577c1a-3e8d-46af-81ea-c924c02ce8d0

PURPOSE OF THIS STUDY
The purpose of this study is to gather information on side effect (adverse reactions) caused by the COVID-19 booster vaccine. We will also compare reported suspected adverse reaction(s) between the different coronavirus vaccines. To expand the existing knowledge about the COVID-19 booster vaccines, it is important to gather information on possible adverse reactions in a structured way.

Who can participate?

  • A person you represent who will soon receive the COVID-19 booster vaccine, or who has received the COVID-19 booster vaccine no more than 2 days ago.

Informed consentQuestions which require an answer in this registration form are marked with an asterisk (*).

In order to participate with the COVID Vaccine Monitor study we need your consent. You will be asked to provide some general information. As soon as your informed consent has been submitted you will receive an email with a link to login get access to your questionnaires. To login you will receive a username and password seperately.
If you have any questions do not hesitate to contact the Drug Safety Research Unit by e-mail covidmonitor@dsru.org or telephone 02380 408600.
  • I have read the privacy statement and the information regarding this study. Any questions I had were answered by contacting the Drug Safety Research Unit
  • I understand that participation of the person I represent is voluntary. I understand that I can decide at any time to stop the participation of the person I represent in this study and do not need to give a reason for my decision.
  • I understand that all information provided will be treated with strict confidentiality.
  • I give permission for data of the person I represent to be used for the purpose of this study, namely, to gather information and expand the existing knowledge about the COVID-19 vaccines. It is important for the Drug Safety Research Unit to know precisely which vaccine brand was administered in order to compare the reported suspected adverse reaction between the administered coronavirus vaccines, gaining more insight in the relevant medical history of participants, reported adverse reactions, the nature of these reactions, the course of these reactions, possible risk factors and the consequences related to health.
  • I understand that my email address will only be used for registration and communication with the Drug Safety Research Unit
  • I understand that my data, except for personal data such as email address, postcode and date of birth, could be used for the wider European study. Several European countries will perform a similar study. Results of this study will be compared to each other. Any data shared for this purpose will be anonymous.
  • As a legal representative, I am 16 years or older.

i
id: 98304386-986d-4447-be5c-e9d2eeae7ce7

Sometimes additional information about reported suspected adverse reactions is necessary. In this case we would like to be able to contact you. By doing so we are able to have complete and reliable data on the medical situation which essential for this study.

As a representative, I give permission to contact me for additional information about the reported suspected adverse reactions.

i
id: cd4d138a-8967-4482-a5b4-9783841c6fb7

I give permission to be contacted by telephone for extra information about his/her pregnancy in case some information is lacking or some information is not entirely clear.

i
id: 2ec28f25-a892-49a2-a04c-d24e0d972ff3

Question *

Please enter your phone number

i
id: d5c157e9-31e3-44f3-9726-4c3d5f310fc4

Question *

What is your email address?
This is the email address where the emails will be received about the questionnaires.

i
id: c283dd74-de4e-4bd8-be93-1233d909654d

Question *

12.c What is the postal code of the person you represent?

i
id: 6dcc00e2-bdad-4383-8149-8aca259e8532

Question *

What is the first name of the person you represent? *

i
id: da2dc1a4-fb5a-4ed4-8200-3e33a57bc74f

Question *

What is the year of birth of the person you represent? *

Result

Powered by Your Research